Molokanova, Olena; Schoenig, Kai; Weng, Shih-Yen et al.
Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammationMATRIX BIOLOGY. Bd. 66. 2018 S. 34-49
Rosigkeit, Sebastian; Meng, Martin; Grunwitz, Christian et al.
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in MiceMOLECULAR PHARMACEUTICS. Bd. 15. H. 9. 2018 S. 3909-3919
Schmidt, Marcus; Weyer-Elberich, Veronika; Hengstler, Jan G. et al.
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient populationBREAST CANCER RESEARCH. Bd. 20. 2018
Shen, Limei; Tenzer, Stefan; Storck, Wiebke et al.
Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responsesJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 142. H. 5. 2018 S. 1558-1570
Kim, Yong Ook; Park, Kyoung-Sook; Engelbogen, Nils et al.
Bimodal Targeted Near Infrared/Positron Emission Tomography Contrast Agent to Image Liver FibrogenesisHEPATOLOGY. Bd. 66. 2017 S. 332A-332A
Sahu, Sanjeeb Kumar; Tiwari, Neha; Pataskar, Abhijeet et al.
FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain developmentNATURE COMMUNICATIONS. Bd. 8. 2017
Sahin, Ugur; Derhovanessian, Evelyna; Miller, Matthias et al.
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerNATURE. Bd. 547. H. 7662. 2017 S. 222-+
Leber, Nadine; Kaps, Leonard; Aslam, Misbah et al.
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particlesJOURNAL OF CONTROLLED RELEASE. Bd. 248. 2017 S. 10-23
Molokanova, O.; Schoenig, K.; Weng, S-Y et al.
Suppression of hepatic fibrosis by efficient Col1a1 silencing using shRNA inducible mouse modelsJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S653-S654
Jabulowsky, Robert A.; Loquai, Carmen; Diken, Mustafa et al.
A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanomaCANCER IMMUNOLOGY RESEARCH. Bd. 4. H. 1. 2016